CLIA Competency Assessment for High-Complexity Labs
I want to start with a scene that plays out in high-complexity labs more often than anyone wants to admit.
Actionable intelligence for clinical pathology and diagnostics.
I want to start with a scene that plays out in high-complexity labs more often than anyone wants to admit.
The central mistake in oncology assay selection is treating genomic breadth as a virtue in itself. It is not. A broad…
A positive nucleic acid amplification test does not, by itself, establish active Clostridioides difficile infection. That…
A whole-slide imaging program can have excellent scanners, validated classifiers, and experienced pathologists—and still produce…
A randomized controlled trial published in JAMA Network Open in 2024 found that emergency department patients with suspected…
Between 60% and 70% of all laboratory errors originate in the preanalytical phase — the operational interval that begins with…
Turnaround time is a cost center. In advanced non-small-cell lung cancer, published clinical data demonstrate that plasma ctDNA…
A MALDI-TOF result can look definitive even when the organism in front of you is telling a different story.
There's a persistent fantasy in computational pathology that AI looks at a slide the way a pathologist does — holistically, all…
Actionable intelligence for clinical pathology and diagnostics.